Alpha-2-adrenergic receptor agonists for the prevention of delirium and cognitive decline after open heart surgery (ALPHA2PREVENT): protocol for a multicentre randomised controlled trial
Main Authors: | Eva Skovlund, Rune Haaverstad, Henrik Zetterberg, Jorunn L Helbostad, Rolf Busund, Johan Raeder, Theis Tønnessen, Torgeir Bruun Wyller, Melanie R Simpson, Nils Kristian Skjærvold, Bjørn Erik Neerland, Svein Aslak Landsverk, Ieva Martinaityte, Hilde Margrethe Norum, Geir Selbaek, Elisabeth Skaar, Arjen JC Slooter, Øyvind Sverre Svendsen, Alexander Wahba |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-06-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/12/6/e057460.full |
Similar Items
-
Effectiveness of 17-Alpha-Hydroxyprogesterone in the Prevention of Preterm Labour
by: Uzma Urooj, et al.
Published: (2023-03-01) -
Screening of Alpha-Glucosidase and Alpha-Amylase Inhibitors in the Descurainia Sophia Flower by Molecular Docking to Prevention the Progression of Diabetes
by: Morteza Sadeghi
Published: (2020-08-01) -
Alpha B-Crystallin in Muscle Disease Prevention: The Role of Physical Activity
by: Ivan Dimauro, et al.
Published: (2022-02-01) -
Alpha-glucosidase inhibitors prevent the assembly and induce a reduction of HCV infectivity
by: Chapel, C, et al.
Published: (2006) -
Folate Receptor Alpha Autoantibodies in Autism Spectrum Disorders: Diagnosis, Treatment and Prevention
by: Natasha Bobrowski-Khoury, et al.
Published: (2021-07-01)